Oliver Laeyendecker
Oliver Laeyendecker
Staff Scientist, NIAID
Adresse e-mail validée de
Citée par
Citée par
Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial
RH Gray, G Kigozi, D Serwadda, F Makumbi, S Watya, F Nalugoda, ...
The lancet 369 (9562), 657-666, 2007
Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda
MJ Wawer, RH Gray, NK Sewankambo, D Serwadda, X Li, ...
The Journal of infectious diseases 191 (9), 1403-1409, 2005
Variation in false-negative rate of reverse transcriptase polymerase chain reaction–based SARS-CoV-2 tests by time since exposure
LM Kucirka, SA Lauer, O Laeyendecker, D Boon, J Lessler
Annals of internal medicine 173 (4), 262-267, 2020
The natural history of hepatitis C virus infection: host, viral, and environmental factors
DL Thomas, J Astemborski, RM Rai, FA Anania, M Schaeffer, N Galai, ...
Jama 284 (4), 450-456, 2000
Male circumcision for the prevention of HSV-2 and HPV infections and syphilis
AAR Tobian, D Serwadda, TC Quinn, G Kigozi, PE Gravitt, ...
New England Journal of Medicine 360 (13), 1298-1309, 2009
Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity
E Shrock, E Fujimura, T Kula, RT Timms, IH Lee, Y Leng, ML Robinson, ...
Science 370 (6520), eabd4250, 2020
Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population
SL Klein, A Pekosz, HS Park, RL Ursin, JR Shapiro, SE Benner, ...
The Journal of clinical investigation 130 (11), 6141-6150, 2020
Circumcision in HIV-infected men and its effect on HIV transmission to female partners in Rakai, Uganda: a randomised controlled trial
MJ Wawer, F Makumbi, G Kigozi, D Serwadda, S Watya, F Nalugoda, ...
The Lancet 374 (9685), 229-237, 2009
Effect of human immunodeficiency virus Type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection
N Kiwanuka, O Laeyendecker, M Robb, G Kigozi, M Arroyo, F McCutchan, ...
The Journal of infectious diseases 197 (5), 707-13, 2008
Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda
JH Oyugi, J Byakika-Tusiime, K Ragland, O Laeyendecker, R Mugerwa, ...
Aids 21 (8), 965-971, 2007
Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: hypervariable region 1 as a decoy
SC Ray, YM Wang, O Laeyendecker, JR Ticehurst, SA Villano, ...
Journal of virology 73 (4), 2938-2946, 1999
The effect of a conditional cash transfer on HIV incidence in young women in rural South Africa (HPTN 068): a phase 3, randomised controlled trial
A Pettifor, C MacPhail, JP Hughes, A Selin, J Wang, FX Gómez-Olivé, ...
The Lancet Global Health 4 (12), e978-e988, 2016
COVID-19 serology at population scale: SARS-CoV-2-specific antibody responses in saliva
N Pisanic, PR Randad, K Kruczynski, YC Manabe, DL Thomas, A Pekosz, ...
Journal of clinical microbiology 59 (1), 10.1128/jcm. 02204-20, 2020
SARS-CoV-2–specific CD8+ T cell responses in convalescent COVID-19 individuals
H Kared, AD Redd, EM Bloch, TS Bonny, H Sumatoh, F Kairi, D Carbajo, ...
The Journal of clinical investigation 131 (5), 2021
Male circumcision decreases acquisition and increases clearance of high-risk human papillomavirus in HIV-negative men: a randomized trial in Rakai, Uganda
RH Gray, D Serwadda, X Kong, F Makumbi, G Kigozi, PE Gravitt, S Watya, ...
The Journal of infectious diseases 201 (10), 1455-1462, 2010
Early outpatient treatment for Covid-19 with convalescent plasma
DJ Sullivan, KA Gebo, S Shoham, EM Bloch, B Lau, AG Shenoy, ...
New England Journal of Medicine 386 (18), 1700-1711, 2022
Comparative performance of five commercially available serologic assays to detect antibodies to SARS-CoV-2 and identify individuals with high neutralizing titers
EU Patel, EM Bloch, W Clarke, YH Hsieh, D Boon, Y Eby, RE Fernandez, ...
Journal of Clinical Microbiology 59 (2), 10.1128/jcm. 02257-20, 2021
Effect of community-based voluntary counselling and testing on HIV incidence and social and behavioural outcomes (NIMH Project Accept; HPTN 043): a cluster-randomised trial
TJ Coates, M Kulich, DD Celentano, CE Zelaya, S Chariyalertsak, ...
The lancet global health 2 (5), e267-e277, 2014
HIV prevention efforts and incidence of HIV in Uganda
MK Grabowski, DM Serwadda, RH Gray, G Nakigozi, G Kigozi, J Kagaayi, ...
New England Journal of Medicine 377 (22), 2154-2166, 2017
HIV subtype D is associated with dementia, compared with subtype A, in immunosuppressed individuals at risk of cognitive impairment in Kampala, Uganda
N Sacktor, N Nakasujja, RL Skolasky, M Rezapour, K Robertson, S Musisi, ...
Clinical Infectious Diseases 49 (5), 780-786, 2009
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20